Form 8-K - Current report

0001467373false00014673732025-02-132025-02-13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 13, 2025

Accenture plc

(Exact name of Registrant as specified in its charter)

Ireland

001-34448

98-0627530

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1 Grand Canal Square

Grand Canal Harbour

Dublin 2, Ireland

(Address of principal executive offices)

Registrant’s telephone number, including area code: (353) (1) 646-2000

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Class A ordinary shares, par value $0.0000225 per share			ACN			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

Item 8.01 Other Events

On February 13, 2025, Julie Sweet, Chair and Chief Executive Officer of Accenture plc, sent a message to all Accenture people providing an update on her health. A copy of her message is attached to this Current Report on Form 8-K as Exhibit 99.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.			Description
99			Message from Julie Sweet, Chair and Chief Executive Officer of Accenture plc
104			The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

---

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: February 13, 2025			ACCENTURE PLC
			By:			/s/ Joel Unruch
			Name:			Joel Unruch
			Title:			General Counsel & Corporate Secretary

Exhibit 99

Subject: Providing an update on my health

To: All Accenture People

I am writing to let you know that I was very recently diagnosed with breast cancer. The good news is that the prognosis from my doctor is excellent; the cancer was caught early, and my condition is curable. In addition, a PET scan confirmed that there is no evidence of cancer elsewhere in my body.

I will undergo surgery next week, and the expected treatment afterwards is radiation. Treatment is likely to last 12 to 16 weeks. I have been advised that I will be able to work substantially as normal, leading the day-to-day operations of the company throughout this process. I will, however, curtail my travel during this period. The Board has been briefed and is fully supportive.

We have an incredible Global Management Committee, supported by our amazing teams around the world. I am confident that we will continue to do what we do best – deliver 360° value for our clients, people, shareholders, partners and communities.

As always, I am grateful for all you do each day for our clients and each other.

Best regards,

Julie

Cover Page	Feb. 13, 2025
Cover [Abstract]
Entity Central Index Key	0001467373
Amendment Flag	false
Document Type	8-K
Document Period End Date	Feb. 13, 2025
Entity Registrant Name	Accenture plc
Entity Incorporation, State or Country Code	L2
Entity File Number	001-34448
Entity Tax Identification Number	98-0627530
Entity Address, Address Line One	1 Grand Canal Square
Entity Address, Address Line Two	Grand Canal Harbour
Entity Address, City or Town	Dublin
Entity Address, Postal Zip Code	2
Entity Address, Country	IE
Country Region	353
City Area Code	1
Local Phone Number	646-2000
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class A ordinary shares, par value $0.0000225 per share
Trading Symbol	ACN
Security Exchange Name	NYSE
Entity Emerging Growth Company	false

---